The oncogenic potential of TRIM24 has been linked to the promotion of the GBM growth via the PI3K/Akt signaling axis (Figure 2a) by affecting Akt phosphorylation and regulating PI3KCA through the interaction of its promoter with the PHD–Bromodomain of TRIM24. The gene discussed is AKT1; the disease is glioblastoma.